Major Drug Companies Agree to Price Negotiations With U.S. Government
Pharmaceutical companies that make the 10 prescription drugs chosen to be the first for price negotiations for Medicare patients have agreed to talks with the government.
Tirzepatide more effective in blood sugar control and body weight loss than semaglutide, shows meta-analysis
A new meta-analysis combining 22 studies, to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2–6 October), shows that tirzepatide is superior to semaglutide for both control of blood sugar and in terms of amount of body weight lost by patients.
Odds of clinically meaningful weight loss low in adults with overweight, obesity
Among adults with overweight or obesity, the annual probability of weight loss of 5 percent or more was achieved by only one in 10, according to a study published online Aug. 7 in JAMA Network Open.
New study finds closing racial health disparity gap and addressing individual health are not mutually exclusive
Over the past decade, much of the U.S. health care industry has begun omitting race when predicting and diagnosing disease, thought of as a way of reducing health disparities and curbing systemic racism in health care.
Study finds fat burning during exercise varies widely between individuals
The best heart rate for burning fat differs for each individual and often does not align with the "fat burning zone" on commercial exercise machines, Icahn School of Medicine at Mount Sinai researchers report.
Healthcare News
525 Shiloh Rd,
Ste 4100,
Plano, TX, 75074
- Mon - Fri: 9:00 am – 5:00 pm
- Sat: 10:00 am – 3:00 pm
- Evening & Weekend:
Available by Appointment